Barrington raised the firm’s price target on Paysign (PAYS) to a range of $6.00-$7.00 from $5 and keeps an Outperform rating on the shares after Q1 results were better than the firm’s as well as consensus expectations. Following the Q1 report, the firm is increasing its 2025 and 2026 adjusted EBITDA estimates to $16.0M and $19.1M from $12.5M and $15.3M, respectively.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PAYS:
- Paysign price target raised to $6 from $5 at DA Davidson
- Buy Rating for PaySign Driven by Strong Financial Performance and Strategic Growth in Pharma Programs
- PaySign Stockholders Approve Key Proposals at Annual Meeting
- PaySign Inc Reports Record Growth Amid Plasma Challenges
- Paysign price target raised to $7 from $6 at Lake Street